Metabolic syndrome is a complex and multi-factor clinical condition characterised by the presence of a set of metabolic dysfunctions. These dysfunctions increase the risk of developing cardiovascular diseases, type 2 diabetes and other chronic diseases. It is essential for pharmaceutical companies to have a detailed overview of metabolic syndrome, causes, symptoms, treatment options and recommendations for customers.
Metabolic syndrome, also known as dysmetabolic syndrome or dysmetabolic disease, is a condition characterised by the presence of multiple risk factors that include abdominal obesity, arterial hypertension, dyslipidaemia, and insulin resistance
Metabolic syndrome is influenced by a combination of genetic, environmental and behavioural factors. Major causes include:
The symptoms of metabolic syndrome can be subtle and are often not immediately recognised, as they manifest as a combination of different clinical signs, rather than a single obvious disease.
One of the most obvious signs is the accumulation of visceral fat, which results in a significant increase in abdominal circumference. This condition is often referred to as central or abdominal obesity, and is a strong indicator of risk for cardiovascular disease and diabetes.
High blood pressure is a common symptom of metabolic syndrome. Often, hypertension may have no obvious symptoms, making regular monitoring of blood pressure crucial. Chronic hypertension can damage blood vessels and increase the risk of heart attack and stroke.
Another key component is changes in blood sugar levels. Insulin resistance may lead to high blood glucose levels, including fasting conditions, and may progress to type 2 diabetes. Associated symptoms may include excessive thirst, frequent urination and tiredness.
Metabolic syndrome often involves an altered lipid profile (dyslipidaemia), characterised by high levels of triglycerides and LDL cholesterol (bad cholesterol), and low levels of HDL cholesterol (good cholesterol). This lipid imbalance can favour atherosclerosis, increasing the risk of coronary artery disease.
This syndrome is often associated with a chronic low-grade inflammatory state, which can contribute to the development of various chronic diseases. Inflammatory markers, such as C-reactive protein (CRP), may be elevated.
Early diagnosis and appropriate management can make a difference in improving patients’ quality of life and reducing the risk of serious diseases.
Treatment of metabolic syndrome requires a multi-factor approach that combines lifestyle changes and, in some cases, drug therapy.
Main intervention strategies include regular physical activity, eating a balanced diet and managing stress.
In some cases, your doctor may prescribe medication to treat the individual components of the metabolic syndrome, such as antihypertensives, oral hypoglycaemics or insulin, and statins or fibrates.
The use of supplements for metabolic syndrome can support other therapies, improving carbohydrate and fat metabolism. For example, chitosan is known for its properties of reducing fat absorption.
In general, the choice of functional foods can play an important role in the management of metabolic syndrome. These foods, in addition to providing essential nutrients, offer health benefits due to the presence of bioactive compounds. For this reason, they are useful for improving various aspects of metabolism and reducing the risks associated with metabolic syndrome.
Healthy eating is crucial for the management of metabolic syndrome. Here are some dietary guidelines to follow, with your doctor’s permission:
Metabolic syndrome is a complex condition that requires an integrated, personalised approach. Knowing the causes, symptoms, and treatment strategies is essential to effectively manage this syndrome and prevent the associated serious complications.